APA
CRSP icon

American Portfolios Advisors’s CRISPR Therapeutics CRSP Stock Holding History

American Portfolios Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.36M Buy
20,785
+905
+5% +$65.6K 0.06% 336
2022
Q2 		$1.21M Buy
19,880
+2,501
+14% +$147K 0.05% 381
2022
Q1 		$1.09M Buy
17,379
+1,634
+10% +$103K 0.04% 460
2021
Q4 		$1.19M Buy
15,745
+684
+5% +$59.8K 0.04% 432
2021
Q3 		$1.69M Buy
15,061
+582
+4% +$73.1K 0.06% 300
2021
Q2 		$2.34M Sell
14,479
-421
-3% -$51.2K 0.09% 224
2021
Q1 		$1.82M Buy
14,900
+1,337
+10% +$202K 0.08% 252
2020
Q4 		$2.08M Buy
13,563
+3,729
+38% +$441K 0.11% 189
2020
Q3 		$823K Buy
9,834
+3,545
+56% +$314K 0.05% 342
2020
Q2 		$462K Buy
6,289
+2,169
+53% +$127K 0.03% 456
2020
Q1 		$175K Buy
4,120
+324
+9% +$16.7K 0.01% 692
2019
Q4 		$231K Buy
3,796
+540
+17% +$29.5K 0.02% 696
2019
Q3 		$133K Buy
3,256
+74
+2% +$3.54K 0.01% 862
2019
Q2 		$150K Buy
3,182
+657
+26% +$26.3K 0.01% 824
2019
Q1 		$90.2K Sell
2,525
-900
-26% -$31.1K 0.01% 944
2018
Q4 		$97.9K Buy
3,425
+275
+9% +$9.56K 0.01% 736
2018
Q3 		$140K Buy
3,150
+50
+2% +$2.62K 0.02% 708
2018
Q2 		$182K Buy
+3,100
New +$177K 0.02% 586

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Portfolios Advisors's CRSP Position: Q3 2022 in Review

American Portfolios Advisors increased its CRISPR Therapeutics (CRSP) stake by 4.6% in Q3 2022, buying an estimated $65.6K and bringing the position to 20,785 shares worth $1.36M. The position accounts for 0.06% of the portfolio, ranked #336.

American Portfolios Advisors first reported a position in CRSP in Q2 2018 and has held it in 18 quarters since. The position peaked at $2.34M in Q2 2021. 436 funds tracked by Wall St. Rank hold CRSP as of Q3 2022.

  • American Portfolios Advisors held 20,785 shares of CRISPR Therapeutics worth $1.36M as of Q3 2022.
  • American Portfolios Advisors bought 905 CRISPR Therapeutics shares in Q3 2022, an estimated $65.6K.
  • CRISPR Therapeutics made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #336 holding.
  • American Portfolios Advisors first reported a position in CRISPR Therapeutics in Q2 2018 and has held it in 18 quarters since.
  • American Portfolios Advisors's CRISPR Therapeutics position peaked at $2.34M in Q2 2021.
  • 436 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.